BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer
British Journal of Cancer 116, 1021 (11 April 2017). doi:10.1038/bjc.2017.40
Authors: Michael J Pishvaian, Andrew V Biankin, Peter Bailey, David K Chang, Daniel Laheru, Christopher L Wolfgang & Jonathan R Brody
http://ift.tt/2mqe6e5
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου